BRAF, KIT, NRAS, GNAQ and GNA11 mutation analysis in cutaneous melanomas in Turkish population
Background: KIT and mitogen-activated protein kinase cascade are important for melanomagenesis. In the present study, we analyzed the frequency of BRAF, NRAS, KIT, GNAQ and GNA11 gene mutations and investigated their association with clinicopathological features of melanomas in Turkish population. M...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | Indian Journal of Pathology and Microbiology |
Subjects: | |
Online Access: | http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2015;volume=58;issue=3;spage=279;epage=284;aulast=Yilmaz |
id |
doaj-33d5bd522e37460cad88543d2e1015b6 |
---|---|
record_format |
Article |
spelling |
doaj-33d5bd522e37460cad88543d2e1015b62020-11-24T23:22:34ZengWolters Kluwer Medknow PublicationsIndian Journal of Pathology and Microbiology0377-49292015-01-0158327928410.4103/0377-4929.162831BRAF, KIT, NRAS, GNAQ and GNA11 mutation analysis in cutaneous melanomas in Turkish populationIsmail YilmazMehmet GamsizkanZafer KucukodaciUfuk BerberDilaver DemirelAptullah HaholuGizem NarliBackground: KIT and mitogen-activated protein kinase cascade are important for melanomagenesis. In the present study, we analyzed the frequency of BRAF, NRAS, KIT, GNAQ and GNA11 gene mutations and investigated their association with clinicopathological features of melanomas in Turkish population. Materials and Methods: Forty-seven primary cutaneous melanomas were included in our study. Sanger sequencing method was used for mutation analysis in all cases. Results: Mean age was 62.1 (29-101) years. Female:male ratio was 17:30. Among 47 melanomas, 14 (29.8%) BRAF, 10 (21.3%) NRAS, 4 (8.5%) KIT and 1(2.1%) GNAQ gene mutations were detected. Two of the KIT mutations were found in acral lentiginous melanoma (ALM). In the head and neck region, mutation frequency was significantly lower than in other locations (P = 0.035). The only GNAQ gene mutation (p.Q209L) was detected in a melanoma arising from blue nevus located on the scalp. None of the melanomas harbored NRAS exon 2, KIT exon 13/17/18, GNAQ exon 4 and GNA11 exon 4/5 mutations. Overall mutation frequency did not show significant difference between metastatic (8/14, 57.1%) and nonmetastatic (18/33, 54.5%) patients. We did not observe any significant association between mutation status and gender or age of various patients. Conclusions: Our results support that BRAF and NRAS gene mutations are common in cutaneous melanomas. The activating mutations of KIT gene are rare and especially seen in ALM. GNAQ and GNA11 mutations are infrequent in cutaneous melanomas and may be associated only with melanomas arising from blue nevus.http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2015;volume=58;issue=3;spage=279;epage=284;aulast=YilmazGene mutationmelanomamutation analysis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ismail Yilmaz Mehmet Gamsizkan Zafer Kucukodaci Ufuk Berber Dilaver Demirel Aptullah Haholu Gizem Narli |
spellingShingle |
Ismail Yilmaz Mehmet Gamsizkan Zafer Kucukodaci Ufuk Berber Dilaver Demirel Aptullah Haholu Gizem Narli BRAF, KIT, NRAS, GNAQ and GNA11 mutation analysis in cutaneous melanomas in Turkish population Indian Journal of Pathology and Microbiology Gene mutation melanoma mutation analysis |
author_facet |
Ismail Yilmaz Mehmet Gamsizkan Zafer Kucukodaci Ufuk Berber Dilaver Demirel Aptullah Haholu Gizem Narli |
author_sort |
Ismail Yilmaz |
title |
BRAF, KIT, NRAS, GNAQ and GNA11 mutation analysis in cutaneous melanomas in Turkish population |
title_short |
BRAF, KIT, NRAS, GNAQ and GNA11 mutation analysis in cutaneous melanomas in Turkish population |
title_full |
BRAF, KIT, NRAS, GNAQ and GNA11 mutation analysis in cutaneous melanomas in Turkish population |
title_fullStr |
BRAF, KIT, NRAS, GNAQ and GNA11 mutation analysis in cutaneous melanomas in Turkish population |
title_full_unstemmed |
BRAF, KIT, NRAS, GNAQ and GNA11 mutation analysis in cutaneous melanomas in Turkish population |
title_sort |
braf, kit, nras, gnaq and gna11 mutation analysis in cutaneous melanomas in turkish population |
publisher |
Wolters Kluwer Medknow Publications |
series |
Indian Journal of Pathology and Microbiology |
issn |
0377-4929 |
publishDate |
2015-01-01 |
description |
Background: KIT and mitogen-activated protein kinase cascade are important for melanomagenesis. In the present study, we analyzed the frequency of BRAF, NRAS, KIT, GNAQ and GNA11 gene mutations and investigated their association with clinicopathological features of melanomas in Turkish population. Materials and Methods: Forty-seven primary cutaneous melanomas were included in our study. Sanger sequencing method was used for mutation analysis in all cases. Results: Mean age was 62.1 (29-101) years. Female:male ratio was 17:30. Among 47 melanomas, 14 (29.8%) BRAF, 10 (21.3%) NRAS, 4 (8.5%) KIT and 1(2.1%) GNAQ gene mutations were detected. Two of the KIT mutations were found in acral lentiginous melanoma (ALM). In the head and neck region, mutation frequency was significantly lower than in other locations (P = 0.035). The only GNAQ gene mutation (p.Q209L) was detected in a melanoma arising from blue nevus located on the scalp. None of the melanomas harbored NRAS exon 2, KIT exon 13/17/18, GNAQ exon 4 and GNA11 exon 4/5 mutations. Overall mutation frequency did not show significant difference between metastatic (8/14, 57.1%) and nonmetastatic (18/33, 54.5%) patients. We did not observe any significant association between mutation status and gender or age of various patients. Conclusions: Our results support that BRAF and NRAS gene mutations are common in cutaneous melanomas. The activating mutations of KIT gene are rare and especially seen in ALM. GNAQ and GNA11 mutations are infrequent in cutaneous melanomas and may be associated only with melanomas arising from blue nevus. |
topic |
Gene mutation melanoma mutation analysis |
url |
http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2015;volume=58;issue=3;spage=279;epage=284;aulast=Yilmaz |
work_keys_str_mv |
AT ismailyilmaz brafkitnrasgnaqandgna11mutationanalysisincutaneousmelanomasinturkishpopulation AT mehmetgamsizkan brafkitnrasgnaqandgna11mutationanalysisincutaneousmelanomasinturkishpopulation AT zaferkucukodaci brafkitnrasgnaqandgna11mutationanalysisincutaneousmelanomasinturkishpopulation AT ufukberber brafkitnrasgnaqandgna11mutationanalysisincutaneousmelanomasinturkishpopulation AT dilaverdemirel brafkitnrasgnaqandgna11mutationanalysisincutaneousmelanomasinturkishpopulation AT aptullahhaholu brafkitnrasgnaqandgna11mutationanalysisincutaneousmelanomasinturkishpopulation AT gizemnarli brafkitnrasgnaqandgna11mutationanalysisincutaneousmelanomasinturkishpopulation |
_version_ |
1725567447892754432 |